Recruiting studies: Myeloproliferative Neoplasms Mpns

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myel
Phase N/A · 2 location(s) · MPN Research Foundation · NCT07362225 A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Phase 1 · 5 location(s) · Prelude Therapeutics · NCT07469891 Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation
Phase 1 · 1 location(s) · University of Chicago · NCT06291987 Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
Phase 1 · 1 location(s) · University of Chicago · NCT03326310 Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Phase 1 · 4 location(s) · Cellenkos, Inc. · NCT05423691 Myeloproliferative Neoplasms (MPNs) Patient Registry
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT02760238 Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk M
Phase 2 · 2 location(s) · University of Southern California · NCT06063486

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.